Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to glioblastoma multiforme treatment market will help companies and investors design strategic landscapes.
The glioblastoma multiforme treatment market in Argentina was valued at USD 13.61 million and In Argentina, high-grade gliomas are frequently reported as malignant tumors in adults and the standard of treatment involves surgery & chemoradiation. The health system of Argentina is complex with high inequality. Some of the people in the country receive highquality healthcare services while others face difficulty accessing primary care.
One of the major advancements in the oncology sector in Argentina was the establishment of National Cancer Institute, which works to reduce cancer mortality in the country while improving the quality of life of cancer patients. It is also responsible for conducting cancer research in the country. Thus, such government initiatives for the betterment of cancer treatment in the country and growing awareness about rare cancer may potentially create moderate to good opportunities for market growth.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina glioblastoma multiforme treatment market , including forecasts for subscribers. This country databook contains high-level insights into Argentina glioblastoma multiforme treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account